We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting

By LabMedica International staff writers
Posted on 24 Mar 2023

Conventional laboratory-based tests may require several days or weeks to generate results. More...

Now, a fast, accurate, and portable DNA analyzer goes from sample to result in approximately an hour, making results more accessible.

The Genomadix Cube from Genomadix (Ottawa, Canada) is a portable molecular analyzer that employs the gold standard Polymerase Chain Reaction (PCR) technique, delivering accurate outcomes without the need for a full-service laboratory. This decentralized testing option is particularly useful for remote industries and communities where access to a complete lab is limited. The PCR molecular diagnostic instrument generates top-quality results outside of a lab setting and is capable of testing for genetic, infectious disease, and environmental targets on a sample-to-result platform.

Collected samples are placed into a disposable DNA test cartridge, which is then inserted into the analyzer. Once inside, the cartridge extracts the DNA/RNA and produces millions of copies using the PCR process. An optical system detects the amplified fluorescence, and algorithms automatically generate a test outcome. The analyzer's portability, user-friendliness, and real-time processing capabilities allow for the swift generation of critical results.

Related Links:
Genomadix 


New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Test
Allplex HPV28 Detection
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.